First Time Loading...

Bone Biologics Corp
NASDAQ:BBLG

Watchlist Manager
Bone Biologics Corp Logo
Bone Biologics Corp
NASDAQ:BBLG
Watchlist
Price: 1.5251 USD -4.68% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

BBLG doesn't have a meaningful market cap.
BBLG's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Bone Biologics Corp. operates as a medical device company, which engages in the research and development of bone regeneration in spinal fusion. [ Read More ]

The intrinsic value of one BBLG stock under the Base Case scenario is 3.4393 USD. Compared to the current market price of 1.5251 USD, Bone Biologics Corp is Undervalued by 56%.

Key Points:
BBLG Intrinsic Value
Base Case
3.4393 USD
Undervaluation 56%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bone Biologics Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BBLG stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Bone Biologics Corp

Provide an overview of the primary business activities
of Bone Biologics Corp.

What unique competitive advantages
does Bone Biologics Corp hold over its rivals?

What risks and challenges
does Bone Biologics Corp face in the near future?

Has there been any significant insider trading activity
in Bone Biologics Corp recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bone Biologics Corp.

Provide P/S
for Bone Biologics Corp.

Provide P/E
for Bone Biologics Corp.

Provide P/OCF
for Bone Biologics Corp.

Provide P/FCFE
for Bone Biologics Corp.

Provide P/B
for Bone Biologics Corp.

Provide EV/S
for Bone Biologics Corp.

Provide EV/GP
for Bone Biologics Corp.

Provide EV/EBITDA
for Bone Biologics Corp.

Provide EV/EBIT
for Bone Biologics Corp.

Provide EV/OCF
for Bone Biologics Corp.

Provide EV/FCFF
for Bone Biologics Corp.

Provide EV/IC
for Bone Biologics Corp.

Show me price targets
for Bone Biologics Corp made by professional analysts.

What are the Revenue projections
for Bone Biologics Corp?

How accurate were the past Revenue estimates
for Bone Biologics Corp?

What are the Net Income projections
for Bone Biologics Corp?

How accurate were the past Net Income estimates
for Bone Biologics Corp?

What are the EPS projections
for Bone Biologics Corp?

How accurate were the past EPS estimates
for Bone Biologics Corp?

What are the EBIT projections
for Bone Biologics Corp?

How accurate were the past EBIT estimates
for Bone Biologics Corp?

Compare the revenue forecasts
for Bone Biologics Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bone Biologics Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bone Biologics Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bone Biologics Corp compared to its peers.

Compare the P/E ratios
of Bone Biologics Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Bone Biologics Corp with its peers.

Analyze the financial leverage
of Bone Biologics Corp compared to its main competitors.

Show all profitability ratios
for Bone Biologics Corp.

Provide ROE
for Bone Biologics Corp.

Provide ROA
for Bone Biologics Corp.

Provide ROIC
for Bone Biologics Corp.

Provide ROCE
for Bone Biologics Corp.

Provide Gross Margin
for Bone Biologics Corp.

Provide Operating Margin
for Bone Biologics Corp.

Provide Net Margin
for Bone Biologics Corp.

Provide FCF Margin
for Bone Biologics Corp.

Show all solvency ratios
for Bone Biologics Corp.

Provide D/E Ratio
for Bone Biologics Corp.

Provide D/A Ratio
for Bone Biologics Corp.

Provide Interest Coverage Ratio
for Bone Biologics Corp.

Provide Altman Z-Score Ratio
for Bone Biologics Corp.

Provide Quick Ratio
for Bone Biologics Corp.

Provide Current Ratio
for Bone Biologics Corp.

Provide Cash Ratio
for Bone Biologics Corp.

What is the historical Revenue growth
over the last 5 years for Bone Biologics Corp?

What is the historical Net Income growth
over the last 5 years for Bone Biologics Corp?

What is the current Free Cash Flow
of Bone Biologics Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bone Biologics Corp.

Financials

Balance Sheet Decomposition
Bone Biologics Corp

Current Assets 3.7m
Cash & Short-Term Investments 3m
Other Current Assets 711.2k
Current Liabilities 831.4k
Accounts Payable 360.7k
Accrued Liabilities 415k
Other Current Liabilities 55.8k
Efficiency

Earnings Waterfall
Bone Biologics Corp

Revenue
0 USD
Operating Expenses
-9.4m USD
Operating Income
-9.4m USD
Other Expenses
479.6k USD
Net Income
-8.9m USD

Free Cash Flow Analysis
Bone Biologics Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BBLG Profitability Score
Profitability Due Diligence

Bone Biologics Corp's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
Negative Net Income
37/100
Profitability
Score

Bone Biologics Corp's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

BBLG Solvency Score
Solvency Due Diligence

Bone Biologics Corp's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Bone Biologics Corp's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BBLG Price Targets Summary
Bone Biologics Corp

There are no price targets for BBLG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BBLG Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BBLG Price
Bone Biologics Corp

1M 1M
-31%
6M 6M
-65%
1Y 1Y
-97%
3Y 3Y
-100%
5Y 5Y
-100%
10Y 10Y
-100%
Annual Price Range
1.5251
52w Low
1.5251
52w High
62.4
Price Metrics
Average Annual Return -35.09%
Standard Deviation of Annual Returns 83.51%
Max Drawdown -100%
Shares Statistics
Market Capitalization 1.3m USD
Shares Outstanding 880 000
Percentage of Shares Shorted 1.78%

BBLG Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Bone Biologics Corp Logo
Bone Biologics Corp

Country

United States of America

Industry

Biotechnology

Market Cap

1.3m USD

Dividend Yield

0%

Description

Bone Biologics Corp. operates as a medical device company, which engages in the research and development of bone regeneration in spinal fusion. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. The firm is also focused on bone regeneration in spinal fusion using the recombinant human protein, known as NELL-1/DBX. The NELL-1/DBX medical device is a combination product which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The NELL-1/DBX Fusion Device offers a range of procedures including Spine Implants, Non-Union Trauma Cases and Osteoporosis. NELL-1 is a function specific recombinant human protein in laboratory bench models to recapitulate normal human growth and development to provide control over bone and cartilage regeneration. The platform technology is its human protein, known as NELL-1, a skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration.

Contact

MASSACHUSETTS
Burlington
2 Burlington Woods Dr Ste 100
+17815524452.0
https://www.bonebiologics.com/

IPO

2015-11-27

Employees

2

Officers

CEO & President
Mr. Jeffrey Frelick
Chief Financial Officer
Ms. Deina H. Walsh
Co-Founder & Member of Scientific Advisory Board
Dr. Shun'ichi Kuroda

See Also

Discover More
What is the Intrinsic Value of one BBLG stock?

The intrinsic value of one BBLG stock under the Base Case scenario is 3.4393 USD.

Is BBLG stock undervalued or overvalued?

Compared to the current market price of 1.5251 USD, Bone Biologics Corp is Undervalued by 56%.